181 related articles for article (PubMed ID: 9404560)
21. Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases.
Sugai T; Sakiyama Y; Matumoto S
Clin Exp Allergy; 1992 Feb; 22(2):275-81. PubMed ID: 1571819
[TBL] [Abstract][Full Text] [Related]
22. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity.
Pucci N; Lombardi E; Novembre E; Farina S; Bernardini R; Rossi E; Favilli T; Vierucci A
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):353-7. PubMed ID: 10669858
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein.
Tsuda S; Kato K; Miyasato M; Sasai Y
J Dermatol; 1992 Apr; 19(4):208-13. PubMed ID: 1607481
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children.
Stelmach I; Gorski P; Jerzynska J; Stelmach W; Majak P; Kuna P
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):67-73. PubMed ID: 12141723
[TBL] [Abstract][Full Text] [Related]
25. Double-blind, randomized, placebo-controlled trial of effect of nedocromil sodium on clinical and inflammatory parameters of asthma in children allergic to dust mite.
Stelmach I; Jerzynska J; Brzozowska A; Kuna P
Allergy; 2001 Jun; 56(6):518-24. PubMed ID: 11421896
[TBL] [Abstract][Full Text] [Related]
26. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
Wüthrich B; Kägi MK; Joller-Jemelka H
Arch Dermatol Res; 1992; 284(6):339-42. PubMed ID: 1284103
[TBL] [Abstract][Full Text] [Related]
27. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction.
Ott NL; Gleich GJ; Peterson EA; Fujisawa T; Sur S; Leiferman KM
J Allergy Clin Immunol; 1994 Jul; 94(1):120-8. PubMed ID: 8027490
[TBL] [Abstract][Full Text] [Related]
28. IgE autoantibodies in atopic dermatitis--occurrence of different antibodies against the CH3 and the CH4 epitopes of IgE.
Czech W; Stadler BM; Schôpf E; Kapp A
Allergy; 1995 Mar; 50(3):243-8. PubMed ID: 7545880
[TBL] [Abstract][Full Text] [Related]
29. Eosinophil cationic protein in sera of patients with atopic dermatitis.
Kapp A; Czech W; Krutmann J; Schöpf E
J Am Acad Dermatol; 1991 Apr; 24(4):555-8. PubMed ID: 2033129
[TBL] [Abstract][Full Text] [Related]
30. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis.
Furue M; Koga T; Yamashita N
Br J Dermatol; 1999 Jan; 140(1):67-72. PubMed ID: 10215770
[TBL] [Abstract][Full Text] [Related]
31. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
32. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
Nishimoto M; Numahara T; Nakashima K; Yoshida T
Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
[TBL] [Abstract][Full Text] [Related]
33. Local production of total IgE and specific antibodies to the house dust mite in adenoid tissue.
Shin SY; Choi SJ; Hur GY; Lee KH; Kim SW; Cho JS; Park HS
Pediatr Allergy Immunol; 2009 Mar; 20(2):134-41. PubMed ID: 18657051
[TBL] [Abstract][Full Text] [Related]
34. Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma.
Türktaş I; Demirsoy S; Koç E; Gökçora N; Elbeg S
Arch Dis Child; 1996 Oct; 75(4):314-8. PubMed ID: 8984917
[TBL] [Abstract][Full Text] [Related]
35. [Responders and nonresponders of ultraviolet A-1 therapy of acute exacerbated atopic eczema].
Kowalzick L; Pönnighaus JM; Suckow M; Waldmann T
Hautarzt; 1997 Sep; 48(9):645-7. PubMed ID: 9410849
[TBL] [Abstract][Full Text] [Related]
36. Serum eosinophil cationic protein in children with atopic dermatitis.
Murat-Susić S; Lipozencić J; Zizić V; Husar K; Marinović B
Int J Dermatol; 2006 Oct; 45(10):1156-60. PubMed ID: 17040428
[TBL] [Abstract][Full Text] [Related]
37. Soluble CD30 and cyclosporine in severe atopic dermatitis.
Caproni M; Salvatore E; Cardinali C; Brazzini B; Fabbri P
Int Arch Allergy Immunol; 2000 Apr; 121(4):324-8. PubMed ID: 10828723
[TBL] [Abstract][Full Text] [Related]
38. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity.
Walker C; Kägi MK; Ingold P; Braun P; Blaser K; Bruijnzeel-Koomen CA; Wüthrich B
Clin Exp Allergy; 1993 Feb; 23(2):145-53. PubMed ID: 8448682
[TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
Schulte-Herbrüggen O; Fölster-Holst R; von Elstermann M; Augustin M; Hellweg R
Int Arch Allergy Immunol; 2007; 144(3):211-6. PubMed ID: 17579279
[TBL] [Abstract][Full Text] [Related]
40. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).
Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A
Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
